These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11719234)

  • 1. Anthrax: a motor protein determines anthrax susceptibility.
    Hanna PC
    Curr Biol; 2001 Nov; 11(22):R905-6. PubMed ID: 11719234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kif1C, a kinesin-like motor protein, mediates mouse macrophage resistance to anthrax lethal factor.
    Watters JW; Dewar K; Lehoczky J; Boyartchuk V; Dietrich WF
    Curr Biol; 2001 Oct; 11(19):1503-11. PubMed ID: 11591317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exclusion of Kif1c as a candidate gene for anthrax toxin susceptibility.
    Nakajima K; Tanaka Y
    Microb Pathog; 2010 May; 48(5):188-90. PubMed ID: 20188815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quickening the pace of anthrax research: three advances point towards possible therapies.
    Chaudry GJ; Moayeri M; Liu S; Leppla SH
    Trends Microbiol; 2002 Feb; 10(2):58-62. PubMed ID: 11827799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthrax toxin uptake by primary immune cells as determined with a lethal factor-beta-lactamase fusion protein.
    Hu H; Leppla SH
    PLoS One; 2009 Nov; 4(11):e7946. PubMed ID: 19956758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice.
    Liu S; Miller-Randolph S; Crown D; Moayeri M; Sastalla I; Okugawa S; Leppla SH
    Cell Host Microbe; 2010 Nov; 8(5):455-62. PubMed ID: 21075356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity.
    Moayeri M; Martinez NW; Wiggins J; Young HA; Leppla SH
    Infect Immun; 2004 Aug; 72(8):4439-47. PubMed ID: 15271901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lethal toxin actions and their consequences.
    Hanna P
    J Appl Microbiol; 1999 Aug; 87(2):285-7. PubMed ID: 10475969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydroepiandrosterone and melatonin prevent Bacillus anthracis lethal toxin-induced TNF production in macrophages.
    Shin S; Hur GH; Kim YB; Yeon GB; Park KJ; Park YM; Lee WS
    Cell Biol Toxicol; 2000; 16(3):165-74. PubMed ID: 11032360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening inhibitors of anthrax lethal factor.
    Tonello F; Seveso M; Marin O; Mock M; Montecucco C
    Nature; 2002 Jul; 418(6896):386. PubMed ID: 12140548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin.
    Sapra R; Gaucher SP; Lachmann JS; Buffleben GM; Chirica GS; Comer JE; Peterson JW; Chopra AK; Singh AK
    Microb Pathog; 2006; 41(4-5):157-67. PubMed ID: 16950595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric pH and Toxin Factors Modulate Infectivity and Disease Progression After Gastrointestinal Exposure to Bacillus anthracis.
    Xie T; Rotstein D; Sun C; Fang H; Frucht DM
    J Infect Dis; 2017 Dec; 216(11):1471-1475. PubMed ID: 28968672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
    Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the functions of anthrax toxin.
    Banks DJ; Ward SC; Bradley KA
    Expert Rev Mol Med; 2006 Apr; 8(7):1-18. PubMed ID: 16608555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthrax lethal factor inhibition.
    Shoop WL; Xiong Y; Wiltsie J; Woods A; Guo J; Pivnichny JV; Felcetto T; Michael BF; Bansal A; Cummings RT; Cunningham BR; Friedlander AM; Douglas CM; Patel SB; Wisniewski D; Scapin G; Salowe SP; Zaller DM; Chapman KT; Scolnick EM; Schmatz DM; Bartizal K; MacCoss M; Hermes JD
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7958-63. PubMed ID: 15911756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and systemic effects of anthrax lethal toxin and edema toxin.
    Moayeri M; Leppla SH
    Mol Aspects Med; 2009 Dec; 30(6):439-55. PubMed ID: 19638283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibitors prevent caspase-1-mediated disease in rodents challenged with anthrax lethal toxin.
    Muehlbauer SM; Lima H; Goldman DL; Jacobson LS; Rivera J; Goldberg MF; Palladino MA; Casadevall A; Brojatsch J
    Am J Pathol; 2010 Aug; 177(2):735-43. PubMed ID: 20595632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthrax toxin: the long and winding road that leads to the kill.
    Abrami L; Reig N; van der Goot FG
    Trends Microbiol; 2005 Feb; 13(2):72-8. PubMed ID: 15680766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.
    Karginov VA; Nestorovich EM; Moayeri M; Leppla SH; Bezrukov SM
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15075-80. PubMed ID: 16214885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor contributes to Bacillus anthracis lethal toxin-associated damage.
    Rivera J; Sellers RS; Zeng W; van Rooijen N; Casadevall A; Goldman DL
    J Biol Chem; 2014 Mar; 289(10):7131-7141. PubMed ID: 24478317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.